contact profile privacysearch log in
HomeAwards SUO Research Scholar Updates

SUO Research Scholar Updates

Since 2014, SUO has sponsored several awards for the Urology Care Foundation’s Research Scholar program, in order to fund exceptional early-career investigators’ projects in urologic oncology. Each year, we invite the awardees to present an update on their research, and continue to be impressed by the talent and ingenuity of these young urologists.


    2022

    Laura Bukavina, MD , The Research Institute of Fox Chase Cancer Center
    Mentor: Philip Abbosh, MD, PhD
    Investigation of Tumor Infiltrating Lymphocytes: An Immunoscore Prediction Model
    Sponsor: Society for Urologic Oncology

    2022

    Karla Parra, PhD , UT Southwestern Medical Center
    Mentor: Ganesh Raj, MD, PhD
    Therapeutic Targeting of Prostate Cancer Metastases

    2021

    Deborah Kaye, MD , Duke University
    Mentors: Peter Ubel, MD; Sharron Docherty, PhD; Kathryn Pollak, PhD; Charles Scales, MD, MPH; and Daniel George, MD
    DECREASING THE FINANCIAL BURDEN FOR PATIENTS WITH ADVANCED PROSTATE CANCER BY UNDERSTANDING PROVIDER DECISION-MAKING

    2021

    Richard Matulewicz, MD , Memorial Sloan-Kettering Cancer Center
    Mentor: Danil Makarov, MD, MHS
    EVALUATION AND VALIDATION OF THE NEW AUA MICROHEMATURIA GUIDELINES

    2021

    Chen Qian, PhD , Cedars-Sinai Medical Center
    Mentors: Michael Freeman, PhD; Beatrice Knudsen, MD, PhD; and Lily Wu, MD, PhD
    TARGETING ONECUT2: DIFFERENTIAL ROUTES TO METASTASIS IN MCRPC

    2021

    Udit Singhal, MD , University of Michigan
    Mentors: Todd Morgan, MD and Daniel Spratt, MD
    COMPREHENSIVE ASSESSMENT OF A NOVEL CLINICAL TRIAL PLATFORM IN UROLOGY

    2020

    Pauline Filippou, MD , University of Washington
    Mentor: John Gore, MD
    Characterizing end-of-life care in bladder cancer patients

    2020

    Chen Qian, PhD , Cedars-Sinai Medical Center
    Mentors: Michael Freeman, PhD; Beatrice Knudsen, MD, PhD; and Lily Wu, MD, PhD
    Targeting ONECUT2: Differential routes to metastasis in mCRPC

    2020

    Andrew Tracy, MD , Memorial Sloan Kettering Cancer Center
    Mentors: Jonathan Coleman, MD & Kwanghee Kim, PhD
    Genomic characterization of the tumor microenvironment in upper tract urothelial carcinoma

    2019

    Xiaosong Meng, MD, PhD , UT Southwestern Medical Center
    Mentors: Vitaly Margulis, MD; Hans Hammers, MD, PhD; Xiankai Sun, PhD
    DETECTION OF INVASIVE RENAL CELL CARCINOMA WITH TARGETED MOLECULAR IMAGING

    2018

    Shawn Dason, MD , Memorial Sloan Kettering Cancer Center
    Phylogenic Analysis of Chemotherapy-Resistant Urothelial Carcinoma of the Bladder

    2018

    Brandon Manley, MD , H. Lee Moffitt Cancer Center and Research Institute
    Mentor: Anthony Magliocco, MD
    Employing Multiparametric Profiling to Characterize Immunotherapy Responders in Clear Cell Renal Cell Carcinoma

    2018

    Karen Wheeler, MD, PhD , University of Texas Health Science Center at San Antonio
    Mentor: Robert Svatek, MD
    Impact of Surgery on Response to Cancer Immunology

    2017

    William B. Tabayoyong, MD, PhD, MS/MSc , University of Texas, MD Anderson Cancer Center
    Mentor: Ashish Kamat, MD, MBBS
    Phenotypic and Functional Characterization of T cells in bladder Cancer Patients Treated with Pembrolizumab, an Anti-PD1 Antibody, Prior to Cystectomy

    2016

    Suk Hyung Lee, PhD , Columbia University Medical Center
    Mentor: Michael Shen, PhD
    Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

    2016

    Simpa S. Salami, MD, MPH , University of Michigan Medical School
    Mentors: Ganesh Palapattu, MD; Scott Tomlins, MD, PhD and Leonard Marks, MD
    Molecular Profiling of Serial Targeted Biopsy Tissue to Predict Progression of Low to High Grade Prostate Cancer

    2016

    Geoff Sonn, MD , Stanford University
    Mentors: Richard Zare, PhD and James Brooks, MD
    Diagnosis of Prostate Cancer by Desorption Electrospray Ionization Mass Spectrometric Imaging of Small Metabolites and Lipids

    2015

    Aditya Bagrodia, MD , Memorial Sloan Kettering Cancer Center
    Mentors: David B. Solit, MD and Jonathan A. Coleman, MD
    The Prognostic and Therapeutic Value of Genomic Alterations and PI3K/AKT/mTOR Aberrations in Upper Tract Urothelial Carcinoma

    2015

    Anobel Y. Odisho, MD, MPH , University of Washington School of Medicine
    Mentor: John L. Gore, MD
    The Impact of Clinical and Demographic Factors on Risk-Adjusted Outcomes for Urologic Cancer Surgery